Nicholas Boston
@Highvista Strategies Llc
Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.
Assets under management
The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
INSMInsmed Inc
| 1.15% | $3.318M 45,447 shares@ $73.0 avg price | Decreased -64.15% |
CPRICapri Holdings Limited
| 1.14% | $3.298M 77,700 shares@ $42.44 avg price | |
AMGNAmgen Inc
| 1.13% | $3.255M 10,101 shares@ $322.21 avg price | New Position |
CARTMaplebear Inc
| 1.11% | $3.198M 78,500 shares@ $40.74 avg price | Decreased -15.58% |
BCYCBicycle Therapeutics Plc
| 1.09% | $3.158M 139,544 shares@ $22.64 avg price | Increased 9.66% |
MSFTMicrosoft Corp
| 1.08% | $3.123M 7,258 shares@ $430.31 avg price | Decreased -20.74% |
SYRESpyre Therapeutics Inc
| 1.07% | $3.098M 105,351 shares@ $29.42 avg price | Decreased -7.22% |
XOMAXoma Royalty Corporation
| 1.05% | $3.033M 114,548 shares@ $26.48 avg price | Decreased -3.65% |
KROSKeros Therapeutics Inc
| 1.05% | $3.026M 52,107 shares@ $58.07 avg price | Increased 32.9% |
NUVLNuvalent Inc
| 1.03% | $2.969M 29,018 shares@ $102.3 avg price | Increased 1.12% |